Lilly Pulitzer is known for its vibrant dresses, and so many notable styles are included in the sale. Take, for example, this long-sleeve fit-and-flare maxi dress that’s 50 percent off today.

The 2025 Lilly Pulitzer Sunshine Sale has up to 70% off activewear, dresses, sweaters, accessories, home decor, and more. This rare event happens twice a year—shop now before your favorites sell ...

Score darling dresses ... well into the winter season, Lilly Pulitzer always finds a way to get us excited for spring and summer. The beloved brand’s Sunshine Sale is back once again to kick ...

The Pulitzer Prize board is asking a judge to hit ... during his first term in a defamation case brought against him by Summer Zervos, a former contestant on his show “The Apprentice.” ...

In “Lilly,” writer-director Rachel Feldman follows the era-defining work of one such everyday woman: trailblazer Lilly Ledbetter, a pioneer from humble beginnings who took her employer ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Senior equity analysts at StockNews.com upgraded Eli Lilly (LLY, Financial) stock from 'hold' to 'buy' as its stock has shifted positively. Analysts say the upgrade is a sign of increased ...

👉 Go straight to Michael Kors sale 🛍️ Shop handbag deals 🛍️ Shop clothing deals 🛍️ Shop accessory deals We've got our eyes on this Snake Print Georgette Smocked Shirt Dress, a midi style designed ...

Unlike casual language learners — say, in a high school French class, or on Duolingo — for the characters in Sanaz Toossi’s Pulitzer-winning “English,” language acquisition feels imperative.

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.